Table 5.
Clinical and public health outcomes among persons with seroincident SARS-CoV-2, May 2020-January 2021
| N | % | |
|---|---|---|
| Total | 161 | 50% |
| Symptoms and clinical outcomes | ||
| PCR confirmed diagnosis | 43 | 26.7 |
| Asymptomatic * | 45 | 28 |
| Mild (symptomatic, but didn’t seek care) | 99 | 61.5 |
| Ever had COVID like illness* | 114 | 70.8 |
| Nasal discharge, congestion or sneezing | 100 | 62.1 |
| Cough/Cough up phlegm | 75 | 46.6 |
| Cough up blood | 0 | 0 |
| Sore throat | 65 | 40.4 |
| Itchy eye or eye pain | 53 | 32.9 |
| Shortness of breath or chest pain | 32 | 19.9 |
| Stomachache, diarrhea, nausea or vomiting | 67 | 41.6 |
| Rash | 12 | 7.5 |
| Loss of smell | 31 | 19.3 |
| Headache | 89 | 55.3 |
| Fever, chills or repeated chills | 44 | 27.3 |
| Myalgia | 58 | 36 |
| Ever hospitalized | 4 | 2.5 |
| Public health outcomes and testing history | ||
| Ever tested for COVID | 97 | 60.3 |
| Positive SARS-CoV-2 PCR test | 43 | 26.7 |
| Isolated from people outside household | 47 | 29.2 |
| Isolated from people within household ** | 28 | 17.4 |
| Quarantined after contact with COVID | 31 | 19.3 |
| Asked about contacts after COVID diagnosis | 31 | 19.3 |
| Told about contacts with COVID case | 19 | 11.8 |
| Encouraged to get tested because of exposure to case | 10 | 6.2 |
| Told to stay home for a period of time | 8 | 5 |
*
Based on Council of State and Territorial Epidemiologists case definition
**
Among those with others in the household